Contribution: Industrial Research Assistance Program – Contributions to Firms
Neurodyn Life Sciences Inc.
$80,713.00
E! 13266 - UK-NitroGelCap: Development of an Enhanced Soft Gel Encapsulation Process That Reduces Product Exposure to Oxygen
FY 2019-20 · 2019-10-21
Summary
E! 13266 - UK-NitroGelCap: The two partners are Neurodyn Life Sciences (NLS), a Canadian partner producing a nutraceutical to improve brain health, and the project lead firm Agroceutical Products (APL), a British company involved in producing Galanthamine, an active from Daffodils, with expertise in formulation of pharmaceuticals and other actives. The technology development will provide enhanced product stability by protecting oxidation sensitive components of brain active dietary supplements from oxidation during the processes required for manufacturing (MFG) and post MFG (packaged) goods.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Charlottetown|Charlottetown, Prince Edward Island, Canada
Recipient Type
For-profit organization
Business Number
841463342
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2019-10-21 | 2019-20 | $80,713.00 |
| 1 | 2019-10-21 | 2019-20 | $80,713.00 |
| 2 | 2019-10-21 | 2019-20 | $80,713.00 |
| 3 | 2019-10-21 | 2019-20 | $80,713.00 |
| 4 | 2019-10-21 | 2019-20 | $80,713.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 61 jours.
Agreement End Date
2021-11-30
Agreement Number
937378
Agreement Start Date
2019-10-21
Agreement Title
E! 13266 - UK-NitroGelCap: Development of an Enhanced Soft Gel Encapsulation Process That Reduces Product Exposure to Oxygen
Agreement Title (French)
E! 13266 - UK-NitroGelCap : Mise au point d'un procédé amélioré d'encapsulation en gel mou qui réduit l'exposition du produit à l'oxygène.
Agreement Type
Contribution
Agreement Value
$80,713.00
Amendment Date
2021-10-20
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
E! 13266 - UK-NitroGelCap: The two partners are Neurodyn Life Sciences (NLS), a Canadian partner producing a nutraceutical to improve brain health, and the project lead firm Agroceutical Products (APL), a British company involved in producing Galanthamine, an active from Daffodils, with expertise in formulation of pharmaceuticals and other actives. The technology development will provide enhanced product stability by protecting oxidation sensitive components of brain active dietary supplements from oxidation during the processes required for manufacturing (MFG) and post MFG (packaged) goods.
Description (French)
E! 13266 - UK-NitroGelCap : Les deux partenaires sont Neurodyn Life Sciences (NLS), un partenaire canadien qui produit un nutraceutique pour améliorer la santé du cerveau, et la société principale du projet, Agroceutical Products (APL), une société britannique spécialisée dans la production de galanthamine, un actif issu des narcisses des prés, disposant de compétences en préparation pharmaceutique et autres actifs. Le développement technologique permettra d'améliorer la stabilité du produit en protégeant les composés sensibles à l'oxydation des suppléments alimentaires actifs du cerveau contre l'oxydation pendant les processus nécessaires à la fabrication (MFG) et après la fabrication (produits emballés) des produits MFG.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
841463342
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
Neurodyn Life Sciences Inc.
Recipient Postal Code
C1A 4P3
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2019-2020-Q3-937378
